ArticleTherapeutic advances in medical oncology2026
Prevalence of gastrointestinal side effects in hepatocellular carcinoma patients receiving sorafenib: a meta-analysis of 136 studies and 14,416 patients.
Nathalie Arendt et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.